Statistical considerations in the choice of endpoint for drug use disorder trials

While it is well established that dichotomizing a quantitative measure invariably results in loss of statistical power, what is less well recognized is the degree of loss in the context of drug use disorder trials. In some cases, the required sample size must be almost doubled to achieve the same level of power.